Intrapleural mitoxantrone for the palliative treatment of malignant pleural effusions
✍ Scribed by Manuel Morales; Maria del Carmen Expósito
- Book ID
- 104742051
- Publisher
- Springer-Verlag
- Year
- 1995
- Tongue
- English
- Weight
- 230 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.
✦ Synopsis
A group of 21 patients with malignant pleural effusions were treated with the instillation of 40 mg mitoxantrone intrapleurally, after complete fluid drainage. There was a 100% complete response rate with no toxic effects (0%). The mean survival of the patients was 57.1 weeks.
📜 SIMILAR VOLUMES
Background. The management of malignant pleural effusions secondary to breast cancer is a difficult problem. In the 1980s tetracycline was probably the most commonly used sclerosing agent, but parenteral tetracycline is no longer available. Therefore, it is important to evaluate alternative sclerosi